TD SYNNEX (SNX) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
10 Jan, 2026Executive summary
Q4 2024 revenue rose 10% year-over-year to $15.8B, with non-GAAP gross billings up 7% to $21.2B and free cash flow of $513M, meeting the $1B full-year target.
FY2024 non-GAAP gross billings reached $80.1B, up 4% year-over-year, and strategic technologies accounted for 26% of Q4 billings.
Returned $750M to shareholders in FY24, representing 72% of free cash flow, through $612M in share repurchases and $138M in dividends.
Strong performance in Endpoint and Advanced Solutions, with double-digit growth in cloud, cybersecurity, and Hyve.
Cash provided by operations was $562M in Q4 and $1.2B for the year.
Financial highlights
Q4 gross profit was $1.04B, with a gross margin of 6.6% (down 50 bps year-over-year); Q4 operating income was $325M, up 13% year-over-year.
Q4 non-GAAP net income was $263M; non-GAAP diluted EPS was $3.09; FY24 non-GAAP diluted EPS was $11.68.
Q4 cash conversion cycle improved to 18 days from 23 days year-over-year.
FY24 adjusted EBITDA was $1.74B; adjusted ROIC was 10.0%.
Returned 72% of FY24 free cash flow to shareholders.
Outlook and guidance
Q1 FY25 non-GAAP gross billings expected at $19.7B–$20.7B; revenue guidance of $14.4B–$15.2B.
Q1 FY25 non-GAAP net income: $224M–$266M; non-GAAP diluted EPS: $2.65–$3.15.
Full-year 2025 gross billings expected to grow mid-single digits year-over-year; free cash flow guidance: ~$1.1B.
Quarterly dividend raised 10% to $0.44 per share.
Estimated Q1 FY25 tax rate of 23% and interest expense of $78M.
Latest events from TD SYNNEX
- Key votes include director elections, say-on-pay, auditor ratification, and a charter amendment.SNX
Proxy Filing13 Feb 2026 - Proxy covers director elections, say-on-pay, auditor ratification, and ESG progress.SNX
Proxy Filing13 Feb 2026 - Board seeks approval for director elections, executive pay, auditor ratification, and expanded shareholder rights.SNX
Proxy Filing3 Feb 2026 - Q2 delivered 3% gross billings growth, margin gains, and strong shareholder returns.SNX
Q2 20243 Feb 2026 - Q3 non-GAAP gross billings up 9% to $20.3B; revenue $14.7B; Q4 outlook strong.SNX
Q3 202420 Jan 2026 - Record Q4 and FY results with 15% billings growth, 24% EPS gain, and strong FY26 outlook.SNX
Q4 20258 Jan 2026 - Gross billings up 8%, revenue up 4%, EPS within guidance, and dividend raised 10%.SNX
Q1 202520 Dec 2025 - Board recommends FOR all management proposals and AGAINST lowering the special meeting threshold.SNX
Proxy Filing1 Dec 2025 - Proxy covers director elections, governance reforms, and strong financial and ESG performance.SNX
Proxy Filing1 Dec 2025